- You are here:
- Start
- NICE recommends VeriQ for routine clinical use
NICE recommends VeriQ for routine clinical use
NICE has published medical technology guidance on the VeriQ system for assessing graft flow during coronary artery bypass graft surgery (CABG).
The NICE organization has, after thorough evaluation of clinical as well as economical data, recommend to the British health system (NHS) to implement routine flow measurements with Medistim’s VeriQ system during coronary bypass surgery (CABG). NICE argues that such implementation will provide not only improved health outcomes for the patients, but economic savings for the healthcare system. The economic saving is calculated to be £115 per patient, equal to about $182 or €134.
Worth listening to:
an interview with Mr O’Keefe, a regular user from Cardiff and Mr Groves, from the NICE committee.
NICE guidance, click here
Guidance Documents
PDF format NICE guidance written for patients and carers
documents MTG8 The VeriQ system for assessing graft flow during coronary artery bypass graft surgery:
guidance (web format)
WHY IMPLEMENT THIS TECHNOLOGY? 1) This is a powerpoint presentation written by NICE which discusses why a hospital or department should adopt the VeriQ technology:
http://guidance.nice.org.uk/MTG8/SlideSet/ppt/English 2) This is the costing template and report – a document that explains the economic model and provides support to the hospital and department in their implementation of the guidance:
http://guidance.nice.org.uk/MTG8/CostingTemplate/xls/English